CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 13,793 shares at $1.45 ($20,000)
- 4 Open-market buy Director bought 68,965 shares at $1.45 ($99,999)
- 4 Open-market buy Director bought 689,655 shares at $1.45 ($1,000,000)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 28,700 shares at $1.74 ($50,038)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 2,930 shares (option exercise)
- 4 Grant or award Pauls Matthew acquired 227,272 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 22 · 436 filings